Michael Har-Noy


Dr. Michael Har-Noy Founded Immunovative Therapies, Ltd. in Israel in 2004. Since then, Dr. Michael Har-Noy has been developing unique biologic anti-cancer drugs that create the effect of an allogeneic bone marrow transplant but without significant toxicity. His lead drug, AlloStimTM, is ready for Phase II/III testing. Within the next 6 – 12 months, Dr. Michael Har-Noy will conduct a pivotal trial of AlloStimTM in metastatic colon cancer. Success of this trial would lead to marketing approval of AlloStimTM. The trial will be conducted in Thailand and the United States. Click here to see more detailed information: - https://www.behance.net/michaelhar-noy

Israel michaelharnoy.weebly.com/ 0 Spotted, 0 Points, #293,304 Worldwide